Report · Money and Finance
Most wouldn't pay more than $2,500 for a personalized cancer test
Reading
Most U.S. adults (69%) would not pay more than $2,500 for a highly reliable cancer test that comes with personalized treatment options, in a Verasight survey conducted Aug. 13-18, 2025.
About one-in-six (17%) would go as high as $5,000 and 6% as high as $10,000. A smaller tail would pay far more: 3% up to $20,000 and 5% more than $20,000 if necessary.
Topline
Topline distribution
Most wouldn't pay more than $2,500 for a personalized cancer test.
What is the highest price you are willing to pay for a 95% reliable cancer biomarker test which gives you personalized treatment options?
- Less than $2,500 69.4%
- $2,500 - $5,000 16.7%
- $5,001 - $10,000 6.0%
- More than $20,000 if necessary 5.3%
- $10,001 - $20,000 2.5%
Verasight JSM Omnibus Survey
View sourceMethodology
Full methodology- Mode
- Verasight panel recruited via random address-based sampling, random person-to-person text messaging, and dynamic online targeting
- Field dates
- 2025-08-13 → 2025-08-18
- Base (unweighted)
- 1,000
- Margin of error
- +/- 3.1%
- Module
- Verasight JSM Omnibus Survey
Source
Citation
Verasight JSM Omnibus Survey, fielded August 13-18, 2025, N=1,000 United States adults, +/- 3.1%.